FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Disclosed is use of phenylacetic acid derivatives or salts thereof for producing a medicament for preventing and/or treating osteoporosis, application for production of a medicinal agent for stimulation of bone tissue formation or for stimulation of bone tissue remodeling, application for production of a drug for inhibition of bone tissue resorption.
EFFECT: technical result consists in preventing or reducing loss of bone tissue in animal models of osteoporosis and in increasing the collagen level in the metaphysis of femoral ovariectomized rats; reduction of clastogenesis is judged by reduction of level of acid phosphatase in their blood.
24 cl, 9 dwg, 2 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PHENYLKETON CARBOXYLATE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING AND TREATING OSTEOPOROSIS | 2015 |
|
RU2712027C2 |
SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR SELF-REPAIR AND TISSUE REGENERATION | 2015 |
|
RU2728782C2 |
SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING AND TREATING DIABETES | 2015 |
|
RU2723486C2 |
LIGANDS FOR AGGREGATED MOLECULES OF TAU-PROTEIN | 2009 |
|
RU2518892C2 |
NAPHTHYL-CONTAINING COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF ATTENUATION OF POSTCLIMACTERIC SYNDROME SYMPTOMS AND OTHER ESTROGEN-ASSOCIATED PHYSIOLOGICAL STATES, METHODS OF SYNTHESIS OF NAPHTHYL-CONTAINING COMPOUNDS | 1995 |
|
RU2165924C2 |
ENZYME-ACTIVATING COMPOUNDS AND COMPOSITIONS | 2013 |
|
RU2652989C2 |
ANTITUMOR LAMELLARIN ANALOGS | 2003 |
|
RU2328500C2 |
ANTIDIABETIC OXAZOLIDINEDIONES | 2005 |
|
RU2355682C2 |
SELECTIVE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2011 |
|
RU2609210C2 |
NOVEL DERIVATIVES OF MANDELIC ACID AND THEIR USING AS THROMBIN INHIBITORS | 2001 |
|
RU2300521C2 |
Authors
Dates
2019-12-17—Published
2015-10-08—Filed